Wolfgang C. Winkelmayer

Jan 10, 2025 | digitalcommons.library.tmc.edu | Wolfgang C. Winkelmayer |Susan Arnold |Steven Burke |Glenn M. Chertow

RATIONALE & OBJECTIVE: Prespecified analyses of the PROSTUDY DESIGN: Phase 3, global, open-label, randomized, active-controlled clinical trial. SETTING AND PARTICIPANTS: Erythropoiesis-stimulating agent-untreated patients with anemia and NDD-CKD. INTERVENTION: Eligible patients were randomized 1:1 to receive vadadustat or darbepoetin alfa. OUTCOMES: The primary safety end point was time to first MACE.

Jan 10, 2025 | digitalcommons.library.tmc.edu | Anshul Bhatnagar |Jingbo Niu |Vivian Ho |Wolfgang C. Winkelmayer

RATIONALE AND OBJECTIVE: Recent initiatives aim to improve patient satisfaction and autonomy by increasing the use of peritoneal dialysis (PD) in the United States. However, limited knowledge is available about the costs of different dialysis modalities, particularly those incurred by private insurers. In this study, we compared the costs of injectable dialysis drugs (and their oral equivalents) paid by insurers between privately insured patients receiving hemodialysis and PD.

Sep 30, 2024 | acpjournals.org | Wolfgang C. Winkelmayer

Get full access to this articleView all available purchase options and get full access to this article. Supplemental MaterialAuthor Disclosures (annals-24-02169-jc_supplement-disclosureforms.pdf)Reference1. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2024;105:S117-S314. [PMID: 38490803]

Aug 21, 2024 | ard.bmj.com | Sho Fukui |Wolfgang C. Winkelmayer |Sara K. Tedeschi |Javier Marrugo

AbstractIntroduction Chronic kidney disease (CKD) is a common comorbidity of rheumatoid arthritis (RA). The association of longitudinal RA disease activity with long-term kidney function has remained uncertain. Method We analysed a multicentre prospective RA registry in the USA from 2001 to 2022. The exposure was updated time-averaged Clinical Disease Activity Index (TA-CDAI) categories from study enrolment. The primary outcome was a longitudinal estimated glomerular filtration rate (eGFR) change.

May 23, 2024 | jamanetwork.com | Elizabeth Lorenz |Wolfgang C. Winkelmayer

Living donor kidney transplant is the recommended treatment for patients with kidney failure because of its association with better graft and recipient survival compared with deceased donor kidney transplant or dialysis.1,2 More than 30 000 people donate a kidney across the world every year.3 Donor nephrectomy is a unique surgery that individuals undergo with the purpose of helping someone else.